AMAG Pharmaceuticals Update Announces Preliminary 2012 Financial Results and 2013 Financial Guidance
AMAG Pharmaceuticals (NASDAQ: AMAG) today announced a business
update, including preliminary fourth quarter 2012 financial results and
its outlook for 2013. The company will present further details at the 31st
Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday,
January 9, 2013 at 8:30 a.m. Pacific time.
“AMAG turned a corner in 2012, achieving all of our commercial and
development milestones for the year, which together have placed Feraheme
on a path to realize its full potential, both in the U.S. and abroad,”
stated William Heiden, president and chief executive officer of AMAG.
“Additionally, we believe, that the more efficient cost structure that
we established in 2012, coupled with continued top-line growth, will